Literature DB >> 8908697

New therapeutic approaches based on gene transfer techniques.

H Chong1, R G Vile.   

Abstract

Mesh：

Year:  1996        PMID： 8908697     DOI： 10.1007/bf00820663

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  138 in total

Review 1.  Viral vector systems for gene therapy.

Authors:  D Jolly
Journal:  Cancer Gene Ther       Date:  1994-03       Impact factor: 5.987

2.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

Authors:  F L Moolten
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

Review 3.  The choice of prodrugs for gene directed enzyme prodrug therapy of cancer.

Authors:  T A Connors
Journal:  Gene Ther       Date:  1995-12       Impact factor: 5.250

4.  In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.

Authors:  W H Sun; J K Burkholder; J Sun; J Culp; J Turner; X G Lu; T D Pugh; W B Ershler; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.

Authors:  L Santodonato; M Ferrantini; L Gabriele; E Proietti; M Venditti; P Musiani; A Modesti; A Modica; S D Lupton; F Belardelli
Journal:  Hum Gene Ther       Date:  1996-01       Impact factor: 5.695

6.  Cationic liposome-mediated intravenous gene delivery.

Authors:  Y Liu; D Liggitt; W Zhong; G Tu; K Gaensler; R Debs
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

7.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

8.  Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.

Authors:  R G Vile; R M Diaz; N Miller; S Mitchell; A Tuszyanski; S J Russell
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

9.  Gene therapy for cancer using tumour-specific prodrug activation.

Authors:  J D Harris; A A Gutierrez; H C Hurst; K Sikora; N R Lemoine
Journal:  Gene Ther       Date:  1994-05       Impact factor: 5.250

10.  Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.

Authors:  C A Mullen; M M Coale; R Lowe; R M Blaese
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701
View more
  1 in total

Review 1.  Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer.

Authors:  A B Alexandroff; C A McIntyre; J C Porter; J Zeuthen; R G Vile; D D Taub
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.